Article
Fixed Low-Dose Hydroxyurea Therapy: A Strategy for Reducing Emergency Room Visits and Improving Treatment Adherence in Paediatric Sickle Cell Anaemia in Resource-Limited Settings
2024-07-16
Abstract excerpt
<h4>Background: </h4> Sickle cell anaemia (SCA) is a prevalent genetic disorder in sub-Saharan Africa, characterised by frequent vaso-occlusive crises and other complications. Hydroxycarbamide (hydroxyurea) has proven effective in managing SCA but is underutilised in low- and middle-income countries (LMICs) due to cost and monitoring challenges. This study aims to ascertain the impact of a fixed low-dose hydroxyca...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 35f6c1b5-77cf-5ea7-9ee9-668121dbedbd
- DOI
- 10.22541/au.172115069.98111347/v1
